Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.017,48
-2,25%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Inozyme Pharma Inc (INZY) Inozyme Pharma Inc (INZY) Notizie

Inozyme Pharma Inc

INZY
3,05
0,24 (8,54%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202422:14EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
27/11/202414:30GLOBEInozyme Pharma to Participate in the Piper Sandler 36th..
11/11/202414:30GLOBEInozyme Pharma to Present at Upcoming Investor Conferences
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
05/11/202414:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202414:31EDGAR2Form 8-K - Current report
05/11/202414:30GLOBEInozyme Pharma Reports Third Quarter 2024 Financial Results..
24/10/202422:34EDGAR2Form 8-K - Current report
24/10/202419:15GLOBEInozyme Pharma Announces Positive Interim Data from Phase 1..
17/10/202414:30GLOBEInozyme Pharma Announces Presentation of Interim Data from..
07/10/202414:30GLOBEInozyme Pharma Announces Appointment of Biopharmaceutical..
04/10/202402:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202414:00GLOBEInozyme Pharma Presents New Data at the American Society for..
29/8/202414:30GLOBEInozyme Pharma to Participate at the 2024 Wells Fargo..
06/8/202422:54EDGAR2Form 8-K - Current report
06/8/202422:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/8/202414:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202414:39EDGAR2Form 8-K - Current report
06/8/202414:30GLOBEInozyme Pharma Reports Second Quarter 2024 Financial Results..
25/7/202414:30GLOBEInozyme Pharma Publishes Preclinical Data Supporting INZ-701..
02/7/202414:30GLOBEInozyme Pharma Announces FDA Fast Track Designation for..
21/6/202419:00GLOBEInozyme Pharma Announces Presentation and Sponsored..
30/5/202414:30GLOBEInozyme Pharma to Present at the Jefferies Global Healthcare..
23/5/202414:30GLOBEInozyme Pharma to Present Recently Announced Data from Phase..
08/5/202414:30GLOBEInozyme Pharma to Participate at the Bank of America..
07/5/202414:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:32EDGAR2Form 8-K - Current report
07/5/202414:30GLOBEInozyme Pharma Reports First Quarter 2024 Financial Results..
03/5/202414:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
08/4/202412:30GLOBEInozyme Pharma Announces Positive Topline Data from Ongoing..
06/4/202400:00GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
02/4/202414:30GLOBEInozyme Pharma to Participate at the 23rd Annual Needham..
26/3/202413:30GLOBEInozyme Pharma to Report Topline Data from Ongoing Phase 1/2..
12/3/202413:30GLOBEInozyme Pharma Reports Full Year 2023 Financial Results and..
26/2/202414:30GLOBEInozyme Pharma to Participate in the TD Cowen 44th Annual..
14/2/202414:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202403:06EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202414:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
Apertura: 2,75 Min: 2,75 Max: 3,03
Chiusura: 2,81

La tua Cronologia

NASDAQ
INZY
Inozyme Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network